Table 1.
Clinical Characteristics of All Patients.
| n=126 | ||
|---|---|---|
| Age (years) | 65.0 [53.8, 73.0] | |
| Female | 45 (36) | |
| BMI (kg/m2) | 25.3 [22.6, 29.1] | |
| History of ACS | 31 (25) | |
| History of AMI | 23 (18) | |
| History of UAP | 8 (6) | |
| History of SIHD | 12 (10) | |
| History of PCI | 41 (33) | |
| History of CABG | 2 (2) | |
| History of PAD | 9 (7) | |
| History of HF | 7 (6) | |
| Hypertension | 71 (56) | |
| Diabetes mellitus | 74 (59) | |
| Chronic kidney disease | 54 (43) | |
| Cerebral infarction | 15 (12) | |
| Malignancy | 13 (10) | |
| Current smoker | 31 (25) | |
| Medical therapy on admission | ||
| Statin | 64 (51) | |
| Ezetimibe | 27 (21) | |
| PCSK9I | 1 (1) | |
| n-3 fatty acid sequestrants | 17 (13) |
Data are presented as the median [25%, 75%] or n (%).
BMI: body mass index, ACS: acute coronary syndrome, AMI: acute myocardial infarction, UAP: unstable angina pectoris, SIHD: stable ischemic heart disease, PCI: percutaneous coronary intervention, CABG: coronary artery bypass grafting, PAD: peripheral artery disease, HF: heart failure, PCSK9I: proprotein convertase subtilisin/kexin type9 inhibitor